Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
Compensation Framework Study
First Interim Report
Second Interim Report
The Inquiry Report
Publication Day
Evidence
Evidence
Hearings Archive
Compensation
Support
Confidential Psychological Support
Interim Payments
Support Groups
Get in touch
Infected Blood Support Schemes
Treatment and aftercare
Medical Evidence
Expenses Guidance
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Breadcrumb
Home
Evidence
DHSC0046917_057 - Guidance on the use of Ribavarin and Interferon Alpha for Hepatitis C
DHSC0046917_057 - Guidance on the use of Ribavarin and Interferon Alpha for Hepatitis C
Guidance on the use of Ribavarin and Interferon Alpha for Hepatitis C
Documents
DHSC0046917 057 Guidance on the use of Ribavarin and Interferon Alpha for Hepatitis C
Evidence Information
Witness
Reduction of risk of infection
View other evidence